On October 8, Maryland Securities Commissioner Melanie Senter Lubin announced a Fast-Track Program, launching January 1, to expedite franchise renewal registrations. The program will benefit ...
Alnodesertib, combined with irinotecan, targets ATM-negative metastatic colorectal cancer, showing promise in the STELLA study with favorable safety and clinical activity. The FDA's fast track ...
The Dermatology Division of the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to sonelokimab (SLK) in moderate-to-severe palmoplantar pustulosis (PPP) supported by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results